| Product Code: ETC12838602 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Bulgaria continued to rely on key European countries such as Germany, Netherlands, Switzerland, Ireland, and Metropolitan France for its influenza medication imports. With a low Herfindahl-Hirschman Index (HHI) indicating very low Market Top 5 Importing Countries and Market Competition (HHI) Analysis concentration, the Market Top 5 Importing Countries and Market Competition (HHI) Analysis appears to be competitive and diverse. The impressive Compound Annual Growth Rate (CAGR) of 9.4% from 2020-2024 reflects a healthy and growing demand for influenza medications in Bulgaria. Furthermore, the solid growth rate of 5.48% from 2023-2024 suggests a sustained upward trajectory in the importation of these essential pharmaceutical products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Influenza Medications Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Bulgaria Influenza Medications Market - Industry Life Cycle |
3.4 Bulgaria Influenza Medications Market - Porter's Five Forces |
3.5 Bulgaria Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Bulgaria Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Bulgaria Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Bulgaria Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccinations |
4.2.2 Growing incidences of influenza outbreaks in Bulgaria |
4.2.3 Advancements in influenza medication research and development |
4.3 Market Restraints |
4.3.1 High competition among pharmaceutical companies in the Bulgarian market |
4.3.2 Stringent regulations and approval processes for influenza medications |
4.3.3 Seasonal nature of influenza outbreaks leading to fluctuating demand |
5 Bulgaria Influenza Medications Market Trends |
6 Bulgaria Influenza Medications Market, By Types |
6.1 Bulgaria Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Bulgaria Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Bulgaria Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Bulgaria Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Bulgaria Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Bulgaria Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Bulgaria Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Bulgaria Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Bulgaria Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Bulgaria Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Bulgaria Influenza Medications Market Import-Export Trade Statistics |
7.1 Bulgaria Influenza Medications Market Export to Major Countries |
7.2 Bulgaria Influenza Medications Market Imports from Major Countries |
8 Bulgaria Influenza Medications Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination rates in Bulgaria |
8.2 Number of reported influenza cases in Bulgaria |
8.3 Percentage of market share held by innovative influenza medications in Bulgaria |
8.4 Average time taken for new influenza medications to receive regulatory approval in Bulgaria |
8.5 Rate of adoption of new and advanced influenza medications in Bulgaria |
9 Bulgaria Influenza Medications Market - Opportunity Assessment |
9.1 Bulgaria Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Bulgaria Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Bulgaria Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Bulgaria Influenza Medications Market - Competitive Landscape |
10.1 Bulgaria Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Bulgaria Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here